Oral Assessment of Symptoms in Advanced Cancer
OASis
An Observational Study of the Frequency of Oral Symptoms in Patients With Advanced Cancer
1 other identifier
observational
253
1 country
11
Brief Summary
Observational study of prevalence of oral symptoms in patients with advanced cancer using a novel questionnaire ("Oral symptom assessment scale")
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2014
Shorter than P25 for all trials
11 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 3, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2015
CompletedFirst Submitted
Initial submission to the registry
May 22, 2020
CompletedFirst Posted
Study publicly available on registry
May 28, 2020
CompletedMay 28, 2020
May 1, 2020
11 months
May 22, 2020
May 22, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of oral symptoms (20)
Questionnaire
1 week
Secondary Outcomes (1)
Prevalence of physical / psychological symptoms
1 week
Interventions
Novel questionnaire about oral symptoms ("Oral symptom assessment scale / OSAS), and validated questionnaire about physical and psychological symptoms (Memorial Symptom Assessment Scale / MSAS).
Eligibility Criteria
250 subjects that are either inpatients or outpatients at study sites (hospital and hospices in the United Kingdom).
You may qualify if:
- age \> 18yr; diagnosis of locally advanced / metastatic cancer; already known to the specialist palliative care team
You may not qualify if:
- inability to give informed consent; inability to complete questionnaires
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (11)
Brighton & Sussex University Hospitals
Brighton, East Sussex, BN2 5BE, United Kingdom
East Sussex Healthcare NHS Trust
Eastbourne, East Sussex, BN21 2UD, United Kingdom
Pilgrims Hospice
Margate, Kent, CT9 4AD, United Kingdom
Ellenor Lions Hospice
Northfleet, Kent, DA11 7HQ, United Kingdom
Hospice in the Weald
Pembury, Kent, TN2 4TA, United Kingdom
Wisdom Hospice
Rochester, Kent, ME1 2NU, United Kingdom
Frimley Park Hospital
Camberley, Surrey, GU16 7UJ, United Kingdom
Princess Alice Hospice
Esher, Surrey, KT10 9RL, United Kingdom
Royal Surrey County Hospital
Guildford, Surrey, GU2 7XX, United Kingdom
St. Wilfred's Hospice
Chichester, Wesr Sussex, PO18 8QB, United Kingdom
St. Catherine's Hospice
Crawley, West Sussex, RH10 6BH, United Kingdom
Related Publications (2)
Chang VT, Hwang SS, Feuerman M, Kasimis BS, Thaler HT. The memorial symptom assessment scale short form (MSAS-SF). Cancer. 2000 Sep 1;89(5):1162-71. doi: 10.1002/1097-0142(20000901)89:53.0.co;2-y.
PMID: 10964347RESULTDavies A, Buchanan A, Todd J, Gregory A, Batsari KM. Oral symptoms in patients with advanced cancer: an observational study using a novel oral symptom assessment scale. Support Care Cancer. 2021 Aug;29(8):4357-4364. doi: 10.1007/s00520-020-05903-1. Epub 2021 Jan 8.
PMID: 33416995DERIVED
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrew Davies, MD
Royal Surrey County Hospital NHS Foundation Trust
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 22, 2020
First Posted
May 28, 2020
Study Start
September 3, 2014
Primary Completion
July 30, 2015
Study Completion
July 30, 2015
Last Updated
May 28, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will not share
Currently, there are no plans to make IPD available to other researchers